Quinolone-induced QT interval prolongation: a not-so-unexpected class effect

被引：89

作者：

Ball, P ^{[1
]}

机构：

[1] Univ St Andrews, Sch Biomed Sci, St Andrews, Fife, Scotland

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2000年 / 45卷 / 05期

关键词：

D O I：

10.1093/jac/45.5.557

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：557 / 559

页数：3

相关论文

共 13 条

[1] ANDERSON ME, IN PRESS SPANISH J C
[2] Comparative tolerability of the newer fluoroquinolone antibacterials
Ball, P
Mandell, L
Niki, Y
Tillotson, G
[J]. DRUG SAFETY, 1999, 21 (05) : 407 - 421
[3] Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspective
Bonate, PL
Russell, T
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (04) : 349 - 358
[4] Prolonged QT interval: A tricky diagnosis?
deBruyne, MC
Hoes, AW
Kors, JA
Dekker, JM
Hofman, A
vanBemmel, JH
Grobbee, DE
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (10) : 1300 - 1304
[5] Torsades de pointe probably related to sparfloxacin
Dupont, H
Timsit, JF
Souweine, B
Gachot, B
Wolff, M
Regnier, B
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (04) : 350 - 351
[6] Measurement of QT interval and QT dispersion
Hill, JA
Friedman, PL
[J]. LANCET, 1997, 349 (9056) : 894 - 895
[7] Overview of electrocardiographic and cardiovascular safety data for sparfloxacin
Jaillon, P
Morganroth, J
Brumpt, I
Talbot, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 : 161 - 167
[8] The QT interval and torsade de pointes
Moss, AJ
[J]. DRUG SAFETY, 1999, 21 (Suppl 1) : 5 - 10
[9] OBERG KC, 1995, PHARMACOTHERAPY, V15, P687
[10] Samaha FF, 1999, AM J MED, V107, P528